- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07442708
Segmental Lung Recruitment: a Randomized Controlled Trial
This study compares two ways of reopening collapsed parts of the lung in patients on a ventilator.
In one group, doctors use a small camera (bronchoscope) to guide air pressure directly to the blocked part of the lung. In the other group, increased air pressure is applied to the whole lung using the ventilator.
Patients are carefully monitored to ensure safety.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study will compare two lung recruitment strategies in mechanically ventilated patients with segmental atelectasis.
In the experimental group, patients will undergo bronchoscopy-guided targeted segmental recruitment using endobronchial bloker. A flexible bronchoscope will be introduced through the endotracheal tube and advanced under direct visualization to the affected lung segment. The endobronchial blocker will be positioned to temporarily block the segmental bronchus, creating a closed system. Sustained positive pressure of 30 cmH₂O will be applied directly to the atelectatic segment for 30 minutes, while standard ventilator settings will be maintained for the remainder of the lung. Continuous monitoring of oxygen saturation, heart rate, blood pressure, and end-tidal carbon dioxide will be maintained. The maneuver will be immediately discontinued if oxygen saturation decreases by more than 10%, systolic blood pressure decreases by more than 20%, or heart rate changes by more than 20% from baseline values.
In the control group, patients will receive a conventional whole-lung recruitment maneuver. Continuous positive airway pressure (CPAP) of 40 cmH₂O will be applied to the entire respiratory system for 40 seconds using the ventilator. Monitoring and safety criteria will be identical to those used in the experimental group, and the maneuver will be discontinued if predefined thresholds are exceeded.
All patients will receive lung-protective mechanical ventilation according to current guidelines. Tidal volumes will be maintained at 6-8 mL/kg predicted body weight, plateau pressures will be limited to less than 30 cmH₂O, and positive end-expiratory pressure (PEEP) will be adjusted according to FiO₂-PEEP tables. Permissive hypercapnia will be accepted provided arterial pH remains above 7.20.
The primary outcomes will focus on safety and will include the incidence of clinically significant desaturation (oxygen saturation decrease greater than 5% from baseline) and hemodynamic instability (systolic blood pressure decrease greater than 20 mmHg or need for vasopressor dose escalation) during and within 30 minutes after the maneuver.
Secondary outcomes will include changes in respiratory parameters measured at baseline, 24 hours, and 48 hours after the intervention. These parameters will include the PaO₂/FiO₂ ratio, static respiratory system compliance, driving pressure, plateau pressure, and PEEP. Arterial blood gas analysis will be performed at baseline, 1 hour, 24 hours, and 48 hours to assess pH, PaO₂, PaCO₂, bicarbonate, and base excess.
Clinical outcomes will include duration of mechanical ventilation following the maneuver, length of stay in the intensive care unit, duration of ward treatment after ICU discharge, in-hospital mortality, and 28-day all-cause mortality.
All patients will undergo contrast-enhanced chest computed tomography. Lung parenchyma will be segmented using 3D Slicer software to quantify total lung volume and non-ventilated (pathologic) lung regions. The proportion of non-ventilated lung tissue relative to total lung volume will be calculated. A change greater than 15% in the proportion of non-ventilated lung between baseline and follow-up scans will be considered clinically significant.
Venous blood samples will be collected at baseline, 24 hours, and 48 hours. Serum concentrations of interleukin-2 and interleukin-8 will be measured using ELISA assays. Samples will be analyzed in duplicate, and assay variability will be less than 10%.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Matej Bura, MD
- Phone Number: 00385917387967
- Email: matej.bura@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- treatment in ICU, presence of radiologically or clinically confirmed pulmonary atelectasis during ICU treatment, requirement for mechanical ventilation
Exclusion Criteria:
- primary or secondary lung malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Segmental lung recruitment
Patients will undergo bronchoscopy-guided targeted segmental lung recruitment via endobronchial blocker.
Flexible bronchoscope will be introduced through the endotracheal tube and advanced under direct visualization to the affected lung segment.
The endobronchial blocker will be positioned to temporarily occlude the segmental bronchus, creating a closed system.
Sustained positive pressure of 30 cmH₂O will be applied directly to the atelectatic segment for 30 minutes, while standard ventilator settings will be maintained for the remaining lung tissue.
|
Patients will undergo bronchoscopy-guided targeted segmental lung recruitment via endobronchial blocker.
Flexible bronchoscope will be introduced through the endotracheal tube and advanced under direct visualization to the affected lung segment.
The endobronchial blocker will be positioned to temporarily occlude the segmental bronchus, creating a closed system.
Sustained positive pressure of 30 cmH₂O will be applied directly to the atelectatic segment for 30 minutes, while standard ventilator settings will be maintained for the remaining lung tissue.
|
|
Active Comparator: Control group
Patients in the control group will receive standard recruitment maneuvers using continuous positive airway pressure applied for a short, sustained period at a level consistent with conventional clinical practice.
This approach will reflect the commonly used recruitment strategy in routine care.
|
Patients in the control group received standard recruitment maneuvers consisting of continuous positive airway pressure (CPAP) of 40 cmH₂O applied to the entire respiratory system for 40 seconds.
This approach represents the conventional recruitment strategy used in clinical practice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Safety profile
Time Frame: From enrollment 72 hours
|
The primary safety outcomes will be the incidence of clinically significant desaturation and hemodynamic instability during and within 30 minutes following the recruitment.
|
From enrollment 72 hours
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Protic A, Bura M, Juricic K. A 23-year-old man with left lung atelectasis treated with a targeted segmental recruitment maneuver: a case report. J Med Case Rep. 2020 Jun 24;14(1):77. doi: 10.1186/s13256-020-02409-6.
- Protic A, Bura M, Sustic A, Brusic J, Sotosek V. Segmental Lung Recruitment in Patients with Bilateral COVID-19 Pneumonia Complicated by Acute Respiratory Distress Syndrome: A Case Report. Medicina (Kaunas). 2023 Jan 11;59(1):142. doi: 10.3390/medicina59010142.
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SEGREC2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Segmental Lung Atelectasis
-
Seoul National University HospitalCompletedPulmonary Atelectasis, Postoperative | Atelectasis, CompressionKorea, Republic of
-
Menoufia UniversityCompleted
-
Xuzhou Medical UniversityCompleted
-
Severance HospitalCompletedAtelectasis, PostoperativeKorea, Republic of
-
University General Hospital of PatrasCompletedLung Ultrasound | Postoperative Pulmonary Atelectasis | Postoperative Atelectasis | Lung Ultrasonography Score | Postoperative Pulmonary Complications (PPCs)Greece
-
Samsung Medical CenterCompletedRecruitment | Ventilator Lung | Atelectasis | Postoperative AtelectasisKorea, Republic of
-
Emory UniversityPEEP Medical, LLCCompletedPostoperative AtelectasisUnited States
-
Marmara UniversityCompleted
-
Mansoura UniversityEnrolling by invitationAnesthesia Induced AtelectasisEgypt
-
Capital Medical UniversityRecruiting
Clinical Trials on Segmental lung recruitment
-
Tanta UniversityCompletedObesity, Morbid | Bariatric SurgeryEgypt
-
Tanta UniversityCompletedScoliosis; Adolescence | Postoperative Atelectasis | Lung RecruitmentEgypt
-
Prof. Dr. Cemil Tascıoglu Education and Research...RecruitingGeneral Anesthesia | Mechanical Ventilation | Prone Position | AtelectasisTurkey (Türkiye)
-
Ondokuz Mayıs UniversityRecruitingAtelectasis, PostoperativeTurkey (Türkiye)
-
University of FlorenceUnknownRespiratory Distress SyndromeItaly
-
Alexandria UniversityRecruitingVentilator Lung | Echocardiography | Lung Recruitment | Chest Ultrasound | High Frequency VentilationEgypt
-
Cairo UniversityUnknown
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt
-
University Hospital, CaenNot yet recruitingAcute Respiratory Distress Syndrom
-
Hallym University Kangnam Sacred Heart HospitalCompletedPatients Receiving Protective Lung Ventilation | Patients in Grey Zone (3 < Pulse Pressure Variation (PPV) < 17South Korea